Biomedical Field

Order Description Drawin" rel="nofollow">ing on this week's readin" rel="nofollow">ings and lectures, submit a reflection addressin" rel="nofollow">ing the followin" rel="nofollow">ing: • How would you prioritize the diagnostic vs a therapeutic in" rel="nofollow">in a resource limited environment? • Screenin" rel="nofollow">ing tests have tremendous value but most often priced a fraction of the price of a diagnostic. What are the risks and benefits of a broadly available screenin" rel="nofollow">ing test for “dangerous” genetic marker? • What in" rel="nofollow">information would you need about the screen / test before makin" rel="nofollow">ing your recommendation?